Cancer Screening Tests Included in Health Checkups
Meta Title: Cancer Screening Tests Included in Health Checkups | UK Guide
Meta Title: Cancer Screening Tests Included in Health Checkups | UK Guide
Meta Description: Discover which cancer screening tests are included in health checkups. Learn about key blood-based biomarkers, who should consider screening, and how regular testing supports early awareness.
Cancer screening tests included in health checkups can play a meaningful role in supporting early awareness and proactive wellbeing. In the UK, many individuals are now choosing to include cancer-related blood markers as part of their routine health assessments — not to diagnose cancer, but to flag biomarker changes that may warrant further investigation with a qualified healthcare professional.
Understanding which tests are available, what they measure, and how often to consider them can help you make informed decisions about your personal health monitoring. This guide explains the key cancer screening blood tests commonly included in comprehensive health checkups, what results may indicate, and how private screening in London can complement NHS pathways.
What Are Cancer Screening Blood Tests?
Cancer screening blood tests are laboratory analyses that measure specific biomarkers — proteins, enzymes, or other substances — that may be elevated in the presence of certain cancers. These tests do not diagnose cancer on their own. Rather, they provide data points that, when interpreted alongside clinical context, can sometimes highlight areas that may benefit from further medical advice.
Snippet Definition: Cancer screening blood tests measure specific biomarkers in the blood — such as PSA, CA-125, and CEA — that may be associated with certain types of cancer. These tests are used as part of a broader health assessment and do not provide a definitive diagnosis on their own.
Practical Insight: A single elevated marker does not necessarily mean cancer is present. Many factors, including inflammation, infection, or benign conditions, can influence biomarker levels. Results should always be discussed with an appropriate healthcare professional.
Key Cancer Biomarkers Commonly Included in Health Checkups
Several blood-based biomarkers are routinely included in comprehensive health screening panels. Each one is associated with particular cancer types, though elevations can also occur for non-cancerous reasons.
PSA (Prostate-Specific Antigen)
PSA is a protein produced by the prostate gland. Elevated PSA levels can sometimes suggest prostate-related changes, though raised levels may also be associated with benign prostatic hyperplasia (BPH), urinary infections, or recent physical activity.
- Associated with: Prostate health monitoring
- Normal reference range: Generally below 4.0 ng/mL, though this varies with age
- Important note: PSA is not a definitive cancer test; it is a screening marker
Practical Insight: Men over 50, or those with a family history of prostate cancer, may wish to discuss regular PSA monitoring as part of their health checkups.
CA-125
CA-125 is a protein that can be elevated in ovarian cancer, but it may also rise due to endometriosis, menstruation, pelvic inflammatory disease, or liver conditions.
- Associated with: Ovarian health monitoring
- Normal reference range: Typically below 35 U/mL
- Important note: CA-125 alone cannot confirm or exclude ovarian cancer
CEA (Carcinoembryonic Antigen)
CEA is a glycoprotein that may be elevated in colorectal, pancreatic, lung, and breast cancers. However, smokers and individuals with inflammatory bowel conditions may also present with raised CEA.
- Associated with: Bowel and gastrointestinal health monitoring
- Normal reference range: Generally below 3.0 ng/mL in non-smokers
AFP (Alpha-Fetoprotein)
AFP is primarily associated with liver cancer monitoring. It may also be elevated in hepatitis, cirrhosis, or certain non-cancerous liver conditions.
- Associated with: Liver health monitoring
- Normal reference range: Typically below 10 ng/mL in adults
CA 19-9
CA 19-9 may be elevated in pancreatic, bile duct, and gallbladder cancers. Benign conditions such as pancreatitis and bile duct obstruction can also cause raised levels.
- Associated with: Pancreatic and biliary health monitoring
- Normal reference range: Generally below 37 U/mL
Practical Insight: No single biomarker provides a complete picture. Comprehensive health checkups that include multiple markers alongside standard blood panels — such as a full blood count and liver function tests — offer a broader assessment of overall health.
Comparison of Common Cancer Screening Biomarkers
| Biomarker | Primary Association | Normal Range (Approx.) | May Also Be Elevated In |
|---|---|---|---|
| PSA | Prostate health | < 4.0 ng/mL | BPH, infection, exercise |
| CA-125 | Ovarian health | < 35 U/mL | Endometriosis, menstruation, liver disease |
| CEA | Bowel/colorectal health | < 3.0 ng/mL (non-smokers) | Smoking, inflammatory bowel disease |
| AFP | Liver health | < 10 ng/mL | Hepatitis, cirrhosis |
| CA 19-9 | Pancreatic/biliary health | < 37 U/mL | Pancreatitis, bile duct blockage |
Practical Insight: This table is for general educational purposes. Reference ranges can vary between laboratories and should be interpreted in context by a qualified professional.
Who Should Consider Cancer Screening Blood Tests?
Cancer screening tests included in health checkups may be particularly relevant for individuals who:
- Are aged 40 and over — risk for many cancers increases with age
- Have a family history of specific cancers, such as prostate, ovarian, bowel, or liver cancer
- Have lifestyle risk factors including smoking, high alcohol consumption, or obesity
- Have not had recent health monitoring and wish to establish a baseline
- Are experiencing persistent, unexplained symptoms — though in such cases, seeking medical advice promptly is always recommended
- Want proactive, preventive health awareness as part of their personal wellbeing routine
It is worth noting that the NHS offers structured cancer screening programmes — including bowel cancer screening (age 60–74, expanding to 50), cervical screening, and breast screening. Private cancer screening blood tests can complement these programmes by providing additional biomarker data that may not be covered in standard NHS assessments.
Practical Insight: Screening does not replace seeking medical advice if you have symptoms. If you are experiencing any persistent or concerning changes in your health, contacting an appropriate healthcare service should be your first step.
How Often Should You Include Cancer Markers in a Health Checkup?
There is no single correct answer, as frequency depends on individual risk factors, age, and personal health history. However, general guidance may include:
- Annually: For individuals with elevated risk factors or a significant family history
- Every 1–2 years: For those aged 40 and over as part of a routine health assessment
- As a baseline: For individuals who have never had cancer biomarker testing, establishing baseline values can be helpful for future comparison
Tracking biomarker trends over time can sometimes be more informative than a single reading. A gradual upward trend, even within normal ranges, may sometimes highlight the need for further investigation.
If you are considering regular health monitoring, our health screening packages provide options that include relevant cancer biomarkers alongside comprehensive blood panels.
What Do Cancer Screening Results Mean?
Understanding your results is an essential part of the screening process. Here is a general guide to interpreting cancer biomarker outcomes:
Normal Results
A result within the standard reference range is generally reassuring. However, it is important to understand that normal biomarker levels do not guarantee the absence of disease — some cancers may not elevate specific markers, particularly in early stages.
Elevated Results
An elevated biomarker does not automatically indicate cancer. As outlined above, many benign conditions, medications, and lifestyle factors can influence results. If any marker is raised, seeking further medical advice is the recommended next step.
Borderline Results
Some results may fall at the upper end of the normal range. In these cases, repeat testing after an interval — often 3 to 6 months — can help determine whether the level is stable or trending upward.
Practical Insight: At Health Screening Clinic, our nurse-led team provides clear, easy-to-understand reports with your results. Where biomarker levels fall outside the expected range, we recommend discussing your results with an appropriate healthcare professional for further guidance.
Cancer Screening and Preventive Health in London
London residents have access to both NHS screening programmes and private health screening options. While NHS programmes are excellent for population-level screening of specific cancers, they do not typically include the breadth of blood-based cancer biomarkers available through private health checkups.
For individuals living and working in London, private cancer screening blood tests can offer:
- Convenience — appointments that fit around busy schedules
- Speed — faster turnaround times for results compared to some NHS pathways
- Breadth — access to a wider range of biomarkers within a single health checkup
- Baseline data — useful for ongoing personal health monitoring
This is not a criticism of NHS services — rather, private screening can act as a complementary layer of health awareness, particularly for those who wish to take a more proactive approach.
Frequently Asked Questions
What cancer screening tests are included in a health checkup?
Health checkups may include blood-based cancer screening tests such as PSA, CA-125, CEA, AFP, and CA 19-9. These biomarkers are associated with prostate, ovarian, bowel, liver, and pancreatic health respectively. Inclusion varies depending on the screening package selected.
Can a blood test detect cancer early?
Blood tests can measure biomarkers that may be elevated in the presence of certain cancers. However, they do not diagnose cancer on their own. Elevated results may sometimes highlight the need for further investigation through appropriate healthcare services.
How accurate are cancer screening blood tests?
Cancer biomarker blood tests are useful screening tools, but they are not definitive. Accuracy varies by marker, and false positives or negatives can occur. Results should always be interpreted alongside clinical context and professional medical advice.
Who should get cancer screening blood tests in the UK?
Individuals aged 40 and over, those with a family history of cancer, people with lifestyle risk factors, and anyone wishing to establish a health baseline may benefit from including cancer screening blood tests in their regular health checkups.
How often should I have cancer screening tests?
Frequency depends on individual risk factors. Annual or biennial testing may be appropriate for those at elevated risk, while others may choose periodic baseline assessments. Your healthcare provider can help determine the best interval for your circumstances.
Are private cancer screening tests better than NHS screening?
Neither is inherently better — they serve different purposes. NHS programmes target specific cancers at a population level, while private cancer screening blood tests can offer a broader range of biomarkers and faster results. The two approaches can complement each other effectively.
What happens if my cancer screening results are abnormal?
If any biomarker falls outside the normal reference range, we recommend discussing your results with an appropriate healthcare professional. An elevated marker does not confirm cancer — further investigation may be advised to determine the cause.
Can cancer screening blood tests replace other forms of cancer screening?
No. Blood-based biomarker testing is one component of a comprehensive approach to health monitoring. It should complement, not replace, NHS screening programmes such as bowel cancer screening, cervical screening, and breast screening.
Where can I get cancer screening blood tests in London?
Private clinics across London, including Health Screening Clinic, offer comprehensive health checkups that include cancer screening biomarkers as part of a wider blood testing panel. These are nurse-led services providing testing and reporting only.
Do I need a referral for private cancer screening?
In most cases, no referral is needed for private cancer screening blood tests. You can book directly and attend for a straightforward blood draw. Results are provided with clear reports to support your ongoing health awareness.
Our Commitment to Quality and Accuracy
At Health Screening Clinic, we are a nurse-led service providing blood testing and reporting across London. Our content is written in accordance with UK medical editorial best practice, and our services comply with CQC patient communication standards and ASA advertising guidelines. We do not offer diagnoses, prescriptions, or treatment — we provide accurate, timely testing and clear reporting to support your personal health awareness.
All information in this article is intended for educational purposes and should not be taken as medical advice. If you have specific concerns about your health, please consult an appropriate healthcare professional.
Take a Proactive Step Towards Health Awareness
Understanding what your body is telling you through regular blood-based screening can be an empowering part of your wellbeing routine. Whether you are looking to establish a baseline, monitor known risk factors, or simply invest in peace of mind, cancer screening tests included in health checkups can offer valuable insight.
Explore our available screening options to find a health checkup that suits your needs, or visit our blog for more educational content on preventive health topics.